A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia

(2015) Mark Slifstein et al.   JAMA Psychiatry

Capacity estimates in working memory: Reliability and interrelationships among tasks

(2014) Jared X. Van Snellenberg et al.   COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE

Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder

(2014) Daniel R Rosell et al.   NEUROPSYCHOPHARMACOLOGY

Dopamine D1 sensitivity in the prefrontal cortex predicts general cognitive abilities and is modulated by working memory training

(2013) C. Wass et al.   LEARNING & MEMORY

Animal models of working memory: A review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia

(2012) Paul A. Dudchenko et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112

(2011) Anissa Abi-Dargham et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [11C] NNC112 and [11C] Raclopride

(2010) Mark Slifstein et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists

(2010) Brooke M. Roberts et al.   PSYCHOPHARMACOLOGY

A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia

(2009) Robert H. Pietrzak et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY